Business Context and Reporting Period
Company: Beyond Meat, Inc. (BYND)
Filing Type: Form 10-Q (Unaudited)
Period Ended: June 27, 2026 (Second Quarter of Fiscal Year 2026)
Business Overview: Beyond Meat is a leading plant-based meat company currently executing a strategic repositioning to "Beyond The Plant Protein Company." This strategy involves expanding beyond core meat analogs into adjacent categories, including the launch of "Beyond Immerse," a functional plant-based protein beverage. The company continues to face persistent declines in demand within the traditional plant-based meat category, prompting aggressive cost-reduction initiatives, inventory management, and the cessation of operational activities in China in 2025.
Key Financial Metrics
| Metric | Three Months Ended June 27, 2026 |
Six Months Ended June 27, 2026 |
|---|---|---|
| Net Revenues | $68.8 million | $127.0 million |
| Gross Profit | $5.9 million | $7.9 million |
| Gross Margin | 8.5% | 6.2% |
| Operating Loss | $(30.8) million | $(71.9) million |
| Net Income (Loss) | $16.4 million | $(12.1) million |
| Net Income (Loss) Per Share (Basic) | $0.03 | $(0.03) |
| Cash and Cash Equivalents | $171.4 million | $171.4 million (as of period end) |
| Total Debt Outstanding | $323.8 million | $323.8 million (as of period end) |
| Operating Cash Flow | N/A | $(23.2) million |
Material Changes vs. Prior Comparable Period
- Revenue Decline: Net revenues decreased 8.2% year-over-year (Q2) and 11.6% year-over-year (YTD). This was driven primarily by a 9.5% decrease in volume sold, attributed to weak category demand and reduced distribution points in U.S. retail and foodservice channels.
- Profitability Shift: The company reported a net income of $16.4 million for Q2 2026, compared to a net loss of $31.8 million in Q2 2025. This reversal was primarily due to a non-cash gain on debt extinguishment of $57.7 million resulting from the conversion of 2030 Notes. Excluding this gain, the company continued to incur significant operating losses.
- Operating Expenses: SG&A expenses decreased 18.0% in Q2 and 21.5% YTD. This reduction was significantly aided by an $11.0 million credit from the settlement of an arbitration dispute with a former co-manufacturer.
- Inventory Reduction: Inventory levels decreased from $84.0 million at year-end 2025 to $63.1 million at June 27, 2026, reflecting ongoing efforts to reduce excess and obsolete inventory.
- Debt Restructuring Impact: The company converted $68.8 million in aggregate principal amount of 2030 Notes into common stock during the six-month period, resulting in significant dilution but reducing the debt principal balance.
Guidance, Outlook, Risks, and Unusual Items
- Strategic Repositioning: Management is pivoting to "Beyond The Plant Protein Company," investing in new product adjacencies like the Beyond Immerse beverage line. Success is not guaranteed and requires incremental investment in marketing and distribution.
- Liquidity and Capital Resources: The company has $171.4 million in unrestricted cash. Management believes existing cash balances and anticipated operating cash flows will fund operations for the next twelve months. However, the company is no longer eligible for its ATM Program (Form S-3) and may need to raise additional capital, potentially through dilutive equity or debt issuances.
- Debt Obligations: Significant indebtedness remains, including $29.5 million in 2027 Notes, $208.7 million in 2030 Notes (net of discount), and $110.9 million in Delayed Draw Term Loans. The 2030 Notes bear interest at 7.00% (or 9.50% PIK) and contain embedded derivatives that require fair value remeasurement.
- Legal Proceedings:
- Trademark Litigation: A jury verdict in November 2025 found the company liable for trademark infringement, awarding $38.9 million in damages. The company has accrued this amount and is pursuing post-trial motions.
- Class Action Settlement: A $7.5 million settlement regarding protein content marketing claims was finalized in 2025, with payments completed.
- Co-Manufacturer Arbitration: An $11.0 million settlement with a former co-manufacturer was reached in April 2026, with full payment received by July 2026.
- Internal Controls: The company disclosed material weaknesses in internal controls over financial reporting related to non-routine transactions and inventory valuation. These weaknesses remain unremediated as of June 27, 2026.
- Lease Obligations: In July 2026 (subsequent to period end), the company entered into a Fifth Amendment to its Campus Lease, surrendering approximately 101,612 square feet of space in exchange for a $14.0 million "Compromise Rent" payment obligation over several years.
Key Facts for Investor Verification
- Non-GAAP Adjustments: Verify the sustainability of the Q2 net income, which was driven almost entirely by a $57.7 million non-cash gain on debt extinguishment rather than core operational performance.
- Debt Conversion Dilution: Assess the impact of the 2030 Notes conversions, which resulted in the issuance of over 57 million shares of common stock during the six-month period, significantly increasing the share count.
- Inventory Valuation Risks: Monitor the company's ability to manage inventory levels given the material weakness in inventory valuation controls and the risk of further write-downs if demand does not recover.
- Liquidity Runway: Confirm the company's ability to meet its $15.0 million minimum liquidity covenant under its debt agreements, especially given the negative operating cash flow of $23.2 million for the six-month period.
- Legal Accruals: Track the status of the $38.9 million trademark litigation accrual and any potential additional costs from post-trial motions or appeals.
- Strategic Pivot Execution: Evaluate early performance metrics of the "Beyond Immerse" beverage line and the success of the Big Geyser distribution partnership as a potential growth driver to offset meat category declines.